keyword
https://read.qxmd.com/read/38392325/11-deoxycorticosterone-doc-s-action-on-the-gill-osmoregulation-of-juvenile-rainbow-trout-oncorhynchus-mykiss
#21
JOURNAL ARTICLE
Rodrigo Zuloaga, Luciano Ahumada-Langer, Jorge Eduardo Aedo, Alfredo Molina, Juan Antonio Valdés
In aquaculture, stress can negatively affect fish growth. For years, the cortisol hormone has been thought to play both glucocorticoid and mineralocorticoid functions. Nevertheless, recent research has suggested that 11-deoxycorticosterone (DOC) released during stress could contribute to cortisol actions, though this process is still misunderstood. Here, we evaluated the DOC effects on physiological and early transcriptional responses by RNA-seq. Juvenile rainbow trout were treated with DOC and/or glucocorticoids (mifepristone) or mineralocorticoid (eplerenone) receptor antagonists...
February 9, 2024: Biology
https://read.qxmd.com/read/38363949/a-case-report-of-vaginal-delivery-in-the-second-trimester-of-severe-uterine-prolapse-complicated-with-cervical-incarceration
#22
JOURNAL ARTICLE
Xiaoyue Yang, Tongfu Feng
BACKGROUND: Uterine prolapse is a rare complication of pregnancy, and there is still no consensus on the choice of delivery method. METHODS: The patient's reproductive history included an abortion and eutocic delivery of a girl weighing 3200 g; the current pregnancy was the third pregnancy. Her cervical region was outside the vaginal opening and was red in color, with evident enlargement (6 × 4 cm) and a broken surface. The cervical area also showed white discharge...
February 16, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38361123/effectiveness-and-safety-of-telehealth-medication-abortion-in-the-usa
#23
JOURNAL ARTICLE
Ushma D Upadhyay, Leah R Koenig, Karen Meckstroth, Jennifer Ko, Ena Suseth Valladares, M Antonia Biggs
Telehealth abortion has become critical to addressing surges in demand in states where abortion remains legal but evidence on its effectiveness and safety is limited. California Home Abortion by Telehealth (CHAT) is a prospective study that follows pregnant people who obtained medication abortion via telehealth from three virtual clinics operating in 20 states and Washington, DC between April 2021 and January 2022. Individuals were screened using a standardized no-test protocol, primarily relying on their medical history to assess medical eligibility...
February 15, 2024: Nature Medicine
https://read.qxmd.com/read/38360035/triumphs-and-trials-with-the-uk-abortion-law-the-power-of-collaboration-in-abortion-reform
#24
JOURNAL ARTICLE
Jonathan Lord, Lesley Regan
The UK is usually viewed as having liberal abortion regulations, providing good access to abortion care within a publicly funded health service. However, the underlying laws are authoritarian, dating from an era when public executions drew large crowds and 67 years before women were able to vote. Abortion is only legal when two doctors certify it meets the permitted grounds, and the penalty for self-managed abortion is up to life imprisonment for both the woman and any accomplice. These laws had prevented the use of mifepristone and misoprostol at home...
February 2024: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/38332661/mifepristone-decreases-nicotine-intake-in-dependent-and-non-dependent-adult-rats
#25
JOURNAL ARTICLE
Ranjithkumar Chellian, Azin Behnood-Rod, Adriaan W Bruijnzeel
BACKGROUND: Addiction to tobacco and nicotine products has adverse health effects and afflicts more than a billion people worldwide. Therefore, there is an urgent need for new treatments to reduce tobacco and nicotine use. Glucocorticoid receptor blockade shows promise as a novel treatment for drug abuse and stress-related disorders. AIM: These studies aim to investigate whether glucocorticoid receptor blockade with mifepristone diminishes the reinforcing properties of nicotine in rats with intermittent or daily long access to nicotine...
February 8, 2024: Journal of Psychopharmacology
https://read.qxmd.com/read/38307551/significant-palliative-benefits-following-therapy-with-mifepristone-for-advanced-treatment-resistant-small-cell-lung-cancer
#26
JOURNAL ARTICLE
Jerome H Check, Diane L Check, Trina Poretta DO, Maya Srivastava, Ethan Check
BACKGROUND/AIM: Progesterone receptor antagonists have been found to provide significant extension of life and considerable palliative benefits in a large variety of very advanced cancers. Most of these treated cancers lack the classical nuclear progesterone receptor (nPR). The hypothesized targets are membrane (m) PRs to inhibit progesterone induced blocking factor (PIBF). To date, there have been no case reports documenting the efficacy of PR antagonists for small cell lung cancer (SCLC) confirmed by pathological analysis...
February 2024: Anticancer Research
https://read.qxmd.com/read/38306292/combination-of-mifepristone-and-misoprostol-for-first-trimester-medical-abortion-a-comprehensive-review-of-the-literature
#27
REVIEW
Vera Kelesidou, Ioannis Tsakiridis, Andriana Virgiliou, Themistoklis Dagklis, Apostolos Mamopoulos, Apostolos Athanasiadis, Ioannis Kalogiannidis
IMPORTANCE: Several medications have been used to achieve medical abortion in the first trimester of pregnancy. The most commonly used is the combination of mifepristone and misoprostol; however, different doses and routes of administration have been proposed. OBJECTIVE: The aim of this study was to summarize published data on the effectiveness, adverse effects, and acceptability of the various combinations of mifepristone and misoprostol in medical abortion protocols in the first trimester of pregnancy...
January 2024: Obstetrical & Gynecological Survey
https://read.qxmd.com/read/38305486/changes-in-the-numbers-of-hospital-based-abortions-and-outpatient-early-medical-abortions-in-victoria-2012-22-a-retrospective-cohort-study
#28
JOURNAL ARTICLE
Melvin B Marzan, Eleanor Johnson, Patricia Moore, Heng Jiang, Lisa Hui
OBJECTIVES: To assess changes in the monthly numbers of hospital-based abortions and outpatient early medical abortions in Victoria during January 2012 - March 2022, with a particular interest in the impact of the coronavirus disease 2019 (COVID-19) pandemic. STUDY DESIGN: Population-based retrospective cohort study; time series analysis of Victorian Admitted Episodes Dataset (VAED) and Pharmaceutical Benefits Scheme (PBS) data. SETTING, PARTICIPANTS: All admitted care episodes in Victoria during 1 January 2012 - 31 March 2022 with medical abortion as the principal diagnosis; all PBS claims for mifepristone-misoprostol (MS-2 Step) during 1 January 2015 (date of listing) - 31 March 2022...
February 2, 2024: Medical Journal of Australia
https://read.qxmd.com/read/38293760/hydrocortisone-cardioprotection-in-ischaemia-reperfusion-injury-involves-antioxidant-mechanisms
#29
JOURNAL ARTICLE
Daiana S Escudero, Juliana C Fantinelli, Valeria R Martínez, Luisa F González Arbeláez, María E Amarillo, Néstor G Pérez, Romina G Díaz
BACKGROUND: Glucocorticoid (GR) and mineralocorticoid (MR) receptors are highly expressed in cardiac tissue, and both can be activated by corticosteroids. MR activation, in acute myocardial infarction (AMI), worsens cardiac function, and increase NHE activity contributing to the deleterious process. In contrast, effects of GR activation are not fully understood, probably because of the controversial scenario generated by using different doses or potencies of corticosteroids. AIMS: We tested the hypothesis that an acute dose of hydrocortisone (HC), a low-potency glucocorticoid, in a murine model of AMI could be cardioprotective by regulating NHE1 activity, leading to a decrease in oxidative stress...
January 31, 2024: European Journal of Clinical Investigation
https://read.qxmd.com/read/38270614/activation-of-nop-receptor-increases-vulnerability-to-stress-role-of-glucocorticoids-and-crf-signaling
#30
JOURNAL ARTICLE
Victor A D Holanda, Raissa N de Almeida, Matheus C de Oliveira, Edilson D da Silva Junior, Nicole L Galvão-Coelho, Girolamo Calo', Chiara Ruzza, Elaine C Gavioli
RATIONALE: Recently, we demonstrated that the activation of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) signaling facilitates depressive-like behaviors. Additionally, literature findings support the ability of the N/OFQ-NOP system to modulate the hypothalamic-pituitary-adrenal (HPA) axis. OBJECTIVES: Considering that dysfunctional HPA axis is strictly related to stress-induced psychopathologies, we aimed to study the role of the HPA axis in the pro-depressant effects of NOP agonists...
January 25, 2024: Psychopharmacology
https://read.qxmd.com/read/38265642/a-physician-attack-on-the-fda-will-the-supreme-court-reduce-access-to-mifepristone
#31
JOURNAL ARTICLE
Katie Watson
New England Journal of Medicine, Volume 390, Issue 6, Page 563-567, February 2024.
February 8, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38238738/establishment-of-tumor-microenvironment-preserving-organoid-model-from-patients-with-intracranial-meningioma
#32
JOURNAL ARTICLE
Dokyeong Kim, Junseong Park, Hyeon-Chun Park, Songzi Zhang, Minyoung Park, Soon A Park, Sug Hyung Lee, Youn Soo Lee, Jae-Sung Park, Sin-Soo Jeun, Yeun-Jun Chung, Stephen Ahn
BACKGROUND: Although meningioma is the most common primary brain tumor, treatments rely on surgery and radiotherapy, and recurrent meningiomas have no standard therapeutic options due to a lack of clinically relevant research models. Current meningioma cell lines or organoids cannot reflect biological features of patient tumors since they undergo transformation along culture and consist of only tumor cells without microenvironment. We aim to establish patient-derived meningioma organoids (MNOs) preserving diverse cell types representative of the tumor microenvironment...
January 18, 2024: Cancer Cell International
https://read.qxmd.com/read/38218312/adjuvant-misoprostol-or-mifepristone-for-cervical-preparation-with-osmotic-dilators-before-dilation-and-evacuation
#33
JOURNAL ARTICLE
Stephanie J Lambert, Britt Lunde, Lauren Porsch, Guillaume Stoffels, Laura MacIsaac, Ila Dayananda, Monica V Dragoman
OBJECTIVE: To compare effectiveness and safety of cervical preparation with osmotic dilators plus same-day misoprostol or overnight mifepristone prior to dilation and evacuation (D&E). STUDY DESIGN: We conducted a retrospective cohort analysis of 664 patients initiating abortion between 18 and 22 weeks at an ambulatory health center. We abstracted medical record data from two consecutive 12-month periods in 2017 to 2019. All patients received overnight dilators plus: 600 mcg buccal misoprostol 90 minutes before D&E (period 1); 200 mg oral mifepristone at time of dilators (period 2)...
January 11, 2024: Contraception
https://read.qxmd.com/read/38211763/retrospective-cohort-study-comparing-success-of-medical-management-of-early-pregnancy-loss-in-pregnancies-conceived-with-and-without-medical-assistance
#34
JOURNAL ARTICLE
Valeria Colleselli-Türtscher, Marina Hafenmayr, Alexandra Ciresa-König, Michael Trinker, Sarah Maier, Bettina Toth, Beata Seeber
OBJECTIVE: To compare the success rates of medical management using a combined mifepristone and misoprostol protocol in cases of early pregnancy loss (EPL) between women who conceived without medical assistance and those who conceived through in vitro fertilization (IVF), after fresh or frozen embryo transfer, and evaluate for the predictive factors of success, time to first passage of tissue, and time to complete resolution of pregnancy. DESIGN: Retrospective cohort study...
January 9, 2024: Fertility and Sterility
https://read.qxmd.com/read/38207328/geographic-access-to-early-pregnancy-loss-management
#35
JOURNAL ARTICLE
Jamie W Krashin, Patricia Black, Eric Brannen, Charlotte C Gard, Yan Lin, Margaret Greenwood-Ericksen, Victoria Y Trujillo, Gillian Burkhardt, Courtney A Schreiber
Early pregnancy loss (EPL) is common, but patients face barriers to the most effective medication (mifepristone followed by misoprostol) and procedural (uterine aspiration) management options. This cross-sectional geospatial analysis evaluated access in New Mexico to mifepristone and misoprostol and uterine aspiration in emergency departments (comprehensive) and to uterine aspiration anywhere in a hospital (aspiration) for EPL. Access was defined as a 60-minute car commute. We collected data from hospital key informants and public databases and performed logistical regression to evaluate associations between access and rurality, area deprivation, race, and ethnicity...
January 11, 2024: Obstetrics and Gynecology
https://read.qxmd.com/read/38165689/advance-provision-of-mifepristone-and-misoprostol-via-online-telemedicine-in-the-us
#36
JOURNAL ARTICLE
Abigail R A Aiken, Jennifer E Starling, Daniëlle C van Blitterswijk, Carlijn Looijen, Thijs van Vliet, Dirk R Essink, Rebecca Gomperts
No abstract text is available yet for this article.
February 1, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38152690/phase-specific-differential-regulation-of-mechanical-allodynia-in-a-murine-model-of-neuropathic-pain-by-progesterone
#37
JOURNAL ARTICLE
Sheu-Ran Choi, Dae-Hyun Roh, Ji-Young Moon, Alvin J Beitz, Jang-Hern Lee
Progesterone has been shown to have neuroprotective capabilities against a wide range of nervous system injuries, however there are negative clinical studies that have failed to demonstrate positive effects of progesterone therapy. Specifically, we looked into whether progesterone receptors or its metabolizing enzymes, cytochrome P450c17 and 5α-reductase, are involved in the effects of progesterone on neuropathic pain after chronic constriction injury (CCI) of the sciatic nerve in mice. Intrathecal progesterone administration during the induction phase of chronic pain enhanced mechanical allodynia development and spinal glial fibrillary acidic protein (GFAP) expression, and this enhancement was inhibited by administration of ketoconazole, a P450c17 inhibitor, but not finasteride, a 5α-reductase inhibitor...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/38151223/one-day-versus-two-day-mifepristone-misoprostol-interval-prior-to-initiation-of-misoprostol-during-late-second-trimester-medication-abortion-a-cohort-study
#38
JOURNAL ARTICLE
Abraham Fessehaye Sium, Hana Teklu, Matthew Reeves, Lemi Belay Tolu, Sarah Prager
OBJECTIVES: To compare one-day versus two-day mifepristone-misoprostol interval in late second trimester medication abortion. STUDY DESIGN: This retrospective cohort study was conducted at St. Paul's Hospital Millennium Medical College, in Ethiopia. Data were collected retrospectively and analysed with SPSS 23 using simple descriptive analysis, t-test, Chi-squared test, and regression analysis, as appropriate. P-value<0.05, Adjusted odds ratio (AOR) with 95% CI were used to present results significance...
December 25, 2023: Contraception
https://read.qxmd.com/read/38143596/determinants-of-unsupervised-medical-termination-of-pregnancy-pill-usage-among-women-a-cross-sectional-study-from-north-india
#39
JOURNAL ARTICLE
Reena Pal, Puneet K Gupta, Stuti Tyagi, Himani Palariya, Vidhi Vora, Pratik Agarwal
Background Medical termination of pregnancy (MTP) pills, primarily comprising mifepristone and misoprostol, have proven highly effective and safe under medical supervision. However, unsupervised MTP pill use is on the rise, posing serious health risks. Unsafe abortions remain a global public health concern, with a high incidence in developing countries like India. Methods We conducted a cross-sectional study at a tertiary healthcare center in India from February to April 2023. We enrolled 150 women with a history of unsupervised MTP pill use...
November 2023: Curēus
https://read.qxmd.com/read/38129219/mifepristone-use-among-obstetrician-gynecologists-in-massachusetts-prevalence-and-predictors-of-use
#40
JOURNAL ARTICLE
Emily Newton-Hoe, Alice Lee, Jennifer Fortin, Alisa B Goldberg, Elizabeth Janiak, Sara Neill
OBJECTIVES: We estimated the prevalence of mifepristone use for evidence-based indications among obstetricians-gynecologists in independent practice in Massachusetts and explored the demographic and practice-related factors associated with use. METHODS: We used data from a cross-sectional survey administered to Massachusetts obstetrician-gynecologists identified from the American Medical Association Physician Masterfile. We measured the prevalence of mifepristone use for four clinical scenarios: early pregnancy loss, medication abortion, cervical preparation before dilation and evacuation procedures, and cervical preparation before induction of labor...
December 20, 2023: Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
keyword
keyword
114795
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.